VIRILITAS

Infertility affects 1 in 6 couples, and male factors contribute to half of these cases. Despite this, most of the focus has been on women, and current male fertility diagnostics are often expensive, inaccessible, and lack meaningful insights, leaving many people without clear answers. Led by world-class science, Virilitas aims to empower men in their reproductive health by enabling at-home early detection, prevention, and treatment of male infertility. Our first product integrates state-of-the-art molecular and biochemical technologies to enable early screening of male infertility at home, moments after sample production. This approach allows for timely intervention, speeding access to reproductive care and alleviating the emotional and financial burden on affected couples.